European regulators 'adopted a positive opinion recommending marketing authorization for Moderna’s COVID-19 vaccine,' Moderna says.

Moderna, MoneyGram, GX Acquisition, Byrna Technologies and Zynex are five top stock gainers for Friday.

Stocks moving in premarket trading Friday include Moderna, Didi Global, MoneyGram, Intel and GameStop.

Moderna will replace Alexion Pharmaceuticals in the S&P 500 benchmark following that group's $39 billion takeover by Britain's AstraZeneca in December of last year.

The Dow is on pace for its fourth weekly gain as investors continue to favor stocks in the face of increasing uncertainty over growth and inflation.

Stock futures rise modestly Friday; Intel reportedly is exploring an acquisition of GlobalFoundries; Moderna will join the S&P 500 index; F45 makes muted stock market debut.

Verb Technology, Delta Air Lines, Nikola, Honeywell Industries and U.S. Bancorp are five top stock gainers for Thursday.

AstraZeneca's treatment reduced the combined risk of recurrence of cancer or death from any cause by 42%.

Apellis says the U.S. Food & Drug Administration has approved its Empaveli treatment for a rare blood disease.

The billionaire and crypto investor was in business with Voyager Digital which went bankrupt early July.

The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.

China is a crucial country for Tesla for its domination of the market of electric vehicles.